Woodford sells stake in Reckitt Benckiser
7th Oct 2014 18:12
Woodford Investment Management has added to its core holdings in British American Tobacco and G4S in its portfolio but announced it had sold down its stake in Reckitt Benckiser. Speaking about its decision to sell stakes in the multinational consumer goods company, which had been part of the fund fo
Read moreLondon midday: Mining gains offset by falls from airline, healthcare stocks
7th Oct 2014 11:36
Poor economic data was weighing on UK stocks on Tuesday, with decent gains in the mining sector offset by falls from airlines and pharmaceuticals. The FTSE 100 was trading 0.6% lower at 6,522 by around midday. Nervousness ahead of the start of third-quarter earnings season in the States was also ca
Read moreTuesday broker round-up UPDATE
7th Oct 2014 09:45
African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation. Aggreko: Exane initiates with a target price of 1500p and an underperform rating. Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation. Antofagasta: Canacc
Read moreLondon open: UK stocks drop despite mining gains
7th Oct 2014 08:27
Strong gains in the UK mining sector weren't enough to keep London's FTSE 100 from slipping into the red on Tuesday morning. Indices across Europe were tracking a weak finish on Wall Street and a mixed performance on Asian markets overnight. The FTSE 100 was trading 0.6% lower at 6,526 within the o
Read moreLondon pre-open: Flat start predicted for FTSE
29th Sep 2014 07:42
London's blue chips are set to open flat on Monday morning ahead of a very busy week both at home and abroad, particularly in the latter half. City sources predict the FTSE 100 will open unchanged from Friday's close of 6,649. "European markets are set for an incredibly busy week as we see the f
Read moreAstrazeneca reports latest drug developments
29th Sep 2014 07:09
Drugs maker Astrazeneca has presented data from its pipeline of cancer treatment studies at the 2014 European Society of Medical Oncology Congress. The FTSE 100 group presented preliminary data from its ongoing phase I study of MEDI4736, which is being tested in combination with a drug called tre
Read moreLondon close: Stocks end with modest gain, but down on week overall
26th Sep 2014 16:48
UK stocks ended the final session of the week with a modest rise, although on the week the index was significantly lower. The FTSE 100 closed 9.68 points higher at 6,649.39. Markets are concerned about mounting geopolitical tensions, with the government due to take a vote on whether to participate
Read moreFTSE 100 movers: Easyjet shares take off thanks to comments from Jefferies
26th Sep 2014 16:23
Shares in Easyjet flew higher after Jefferies said the airline was situated to benefit from the recent problems with Air France-KLM, which has been forced to cancel numerous flights due to pilot strike action. The broker also predicted the group would have a positive finish to the year. Astrazeneca
Read moreAstrazeneca receives positive feedback for Moventig
26th Sep 2014 12:36
Astrazeneca shares strained higher on Friday after the company received positive feedback for Moventig, its new treatment for opioid-induced constipation. The committee for Medicinal Products for Human Use of the European Medicines Agency said it had formed a positive opinion on the drug, which has
Read moreLondon midday: Stocks drop as US Treasury acts to block tax inversion deals
23rd Sep 2014 12:38
UK stocks were firmly lower come midday, tracking overnight losses on Wall Street, with investors apparently reacting the US Treasury's move last night to make corporate tax inversions more difficult. Acting as a backdrop, traders were monitoring the first coalition airstrikes against Islamic State
Read moreUS crackdown on tax inversions, AstraZeneca and Shire hit
23rd Sep 2014 11:34
Pharmaceutical companies Shire and AstraZeneca sold off sharply this morning after the US Treasury announced a stricter crackdown against "tax inversion" deals than had been expected. Inversion deals are takeovers designed to reduce the amount of tax US companies pay by moving their headquarters off
Read moreAstrazeneca and Eli Lilly to develop Alzheimer's drug
16th Sep 2014 07:44
Astrazeneca has agreed to jointly develop and commercialise AZD3293, a drug currently being tested as a potential treatment for Alzheimer's disease, with Eli Lilly. Lilly will pay Astra up to $500m in development and regulatory milestone payments, the first of which it expects to receive in the firs
Read moreLondon close: Tesco and HSBC focus investors' attention
1st Sep 2014 17:21
- Chinese, Eurozone and UK manufacturing PMIs fall - Markets looking ahead to BoE, ECB, US jobs data - Perform jumps on Access Industries offer techMARK 2,858.54 +0.26% FTSE 100 6,825.31 +0.08% FTSE 250 15,957.13 +0.45% Figures showing a manufacturing slowdown in the Eurozone, UK and China capped
Read moreLondon close: FTSE ends higher after data-heavy day
29th Aug 2014 17:23
- FTSE 100 closes up 13.95 at 6,819.75 - UK consumer confidence up - House prices inch higher techMARK 2,851.08 +0.17% FTSE 100 6,819.75 +0.20% FTSE 250 15,885.72 -0.16% The biggest London-listed stocks ended the week on an upbeat note after data-heavy session around for the UK, the Eurozone and t
Read moreFTSE 100 movers: Supermarkets provide drag after Tesco issues profit warning
29th Aug 2014 15:46
Shares in Tesco fell sharply on Friday after the supermarket giant announced it expects profits to fall by as much as 27% this year and its interim dividend to be cut by 75%. New boss Dave Lewis, who due to take over from Philip Clarke, will now join the group one month earlier than planned on 1 Sep
Read more